<DOC>
	<DOCNO>NCT00507468</DOCNO>
	<brief_summary>The object open-labeled , uncontrolled pilot study investigate safety feasibility percutaneously transplant autologous bone marrow ( ABM ) cell myocardium use helical needle transendocardial ( TE ) delivery system stable coronary patient ventricular dysfunction due chronic myocardial infarction ( MI ) . A secondary goal ass possibility cell injection could improve ejection fraction ( EF ) .</brief_summary>
	<brief_title>Autologous Bone Marrow Transplanted Via Transendocardial Catheter Chronic Myocardial Infarct Border Zone</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<criteria>Must 18 year age old Able give inform consent Must documentation prior myocardial infarction leave ventricular ejection fraction le 40 percent baseline Must candidate percutaneous heart catheterization Must identifiable area transmural scar within left ventricle Be candidate concurrent ventricular surgical restoration , AICD placement valvular surgery Clinical evidence infection Other complicate cardiovascular abnormality Clinically significant electrocardiographic abnormality Active malignancy Recent history drug alcohol abuse Pregnancy , plan current Artificial aortic valve Ejection fraction le 30 percent baseline Myocardial infarction past 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>bone marrow</keyword>
	<keyword>autologous</keyword>
	<keyword>ejection fraction</keyword>
	<keyword>left ventricle</keyword>
	<keyword>heart attack</keyword>
	<keyword>myocardial infarction</keyword>
	<keyword>leave ventricular dysfunction post myocardial infarction</keyword>
</DOC>